UKRO has an opportunity to contribute to the collection of feedback from UK-based sponsors of UK-EU clinical trials who are faced with new post-Brexit barriers (e.g. additional costs of establishing a legal representative in the EU).
Subscribers involved in UK-EU clinical trials are invited to share their specific examples of additional costs, bureaucracy, or reduced participation in trials by emailing UKRO at malgorzata.czerwiec@ukro.ac.uk by 22 February.
Your testimonies will be shared with colleagues from the NHS Confederation and the DHSC and will help make an evidence-based case for a mutually beneficial solution discussed by the EU-UK Joint Specialised Committees.